Covered recipient · General Payments record
KIRON NAIR
This page merges CMS profile IDs 11303363, 11311515 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2021–2024
$4,236.51
- Reported across 203 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,366.82 | 74 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $202.61 | 18 |
| Celgene Corporation | $105.62 | 6 |
| ABBVIE INC. | $103.22 | 4 |
| Janssen Biotech, Inc. | $94.76 | 5 |
| TerSera Therapeutics LLC | $82.84 | 3 |
| Exelixis Inc. | $82.37 | 4 |
| Acerta Pharma LLC | $74.66 | 4 |
| GlaxoSmithKline, LLC. | $68.44 | 3 |
| Gilead Sciences, Inc. | $63.20 | 3 |
| Regeneron Healthcare Solutions, Inc. | $56.47 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.53 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.74 | 2 |
| SOBI, INC | $45.28 | 2 |
| GENZYME CORPORATION | $43.72 | 2 |
| Incyte Corporation | $43.23 | 2 |
| Sumitomo Pharma America, Inc. | $37.13 | 2 |
| SpringWorks Therapeutics, Inc. | $24.94 | 1 |
| TAIHO ONCOLOGY, INC. | $22.21 | 1 |
| Rigel Pharmaceuticals, Inc. | $21.79 | 1 |
| Karyopharm Therapeutics Inc. | $19.54 | 1 |
| Pharmacosmos Therapeutics Inc. | $18.66 | 1 |
| Merck Sharp & Dohme Corporation | $18.45 | 1 |
| ARRAY BIOPHARMA INC | $17.63 | 1 |
| Stemline Therapeutics Inc. | $14.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (74)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs
- 11303363, 11311515
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.